Danbo Wang
Impact in
- Reproductive Medicine top 2%
- Endometriosis Research and Treatment
- Ovarian cancer diagnosis and treatment
- Obstetrics and Gynecology top 2%
- Endometrial and Cervical Cancer Treatments
Papers in
-
- Endometriosis Research and Treatment 22
- Ovarian cancer diagnosis and treatment 7
-
- Endometrial and Cervical Cancer Treatments 19
- Co-authors
- Yingjie Zhao (19 shared papers)Fang Ren (9 shared papers)Zhuo Yang (5 shared papers)Tong Li (4 shared papers)Zhibo Li (6 shared papers)Peng Chen (5 shared papers)Jiamei Liu (2 shared papers)Hui Liu (5 shared papers)
- Journals
- BMC Cancer (5 papers)Gynecologic Oncology (5 papers)Chemistry - A European Journal (4 papers)Cellular Physiology and Biochemistry (4 papers)International Journal of Gynecological Cancer (4 papers)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Danbo Wang
104 papers receiving 1.8k citations
Danbo Wang's Hit Papers
Peers
Comparison fields: 5 of 79
- Reproductive Medicine 374
- Obstetrics and Gynecology 291
- Cancer Research 182
- Oncology 215
- Materials Chemistry 274
Countries citing papers authored by Danbo Wang
This map shows the geographic impact of Danbo Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danbo Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danbo Wang more than expected).
Fields of papers citing papers by Danbo Wang
This network shows the impact of papers produced by Danbo Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danbo Wang. The network helps show where Danbo Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Danbo Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 107 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial Hit paper breakdown → | 2023 | 238 |
| 2 | 2020 | 97 | |
| 3 | 2016 | 95 | |
| 4 | 2018 | 83 | |
| 5 | 2015 | 66 | |
| 6 | 2023 | 59 | |
| 7 | 2023 | 58 | |
| 8 | 2021 | 56 | |
| 9 | 2012 | 48 | |
| 10 | 2013 | 47 | |
| 11 | 2023 | 47 | |
| 12 | 2019 | 46 | |
| 13 | 2023 | 37 | |
| 14 | 2014 | 36 | |
| 15 | 2021 | 32 | |
| 16 | 2021 | 31 | |
| 17 | 2019 | 30 | |
| 18 | 2017 | 29 | |
| 19 | 2020 | 27 | |
| 20 | 2011 | 26 |
About Danbo Wang
Danbo Wang is a scholar working on Reproductive Medicine, Obstetrics and Gynecology, Oncology, Materials Chemistry and Epidemiology, having authored 107 papers that have together received 1.9k indexed citations. Recurring topics across this work include Endometriosis Research and Treatment (22 papers), Endometrial and Cervical Cancer Treatments (19 papers), Cervical Cancer and HPV Research (10 papers), Covalent Organic Framework Applications (9 papers), PARP inhibition in cancer therapy (8 papers), Ovarian cancer diagnosis and treatment (7 papers), Circular RNAs in diseases (5 papers) and Cancer Immunotherapy and Biomarkers (4 papers). The work is most often cited by research in Reproductive Medicine (374 citations), Obstetrics and Gynecology (291 citations), Cancer Research (182 citations), Oncology (215 citations) and Materials Chemistry (274 citations). Danbo Wang has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Yingjie Zhao, Fang Ren, Zhuo Yang, Tong Li, Zhibo Li, Peng Chen, Jiamei Liu, Hui Liu, Ying-Han Chen and Yan Li. Their work appears in journals such as BMC Cancer, Gynecologic Oncology, Chemistry - A European Journal, Cellular Physiology and Biochemistry and International Journal of Gynecological Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.